Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Effects of avoidance or use of neuromuscular blocking agents on outcomes in tracheal intubation: a Cochrane systematic review

Research output: Contribution to journalReviewResearchpeer-review

  1. Days alive and out of hospital after fast-track total hip and knee arthroplasty: an observational cohort study in 16 137 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Perioperative hyperoxia: why guidelines, research and clinical practice collide

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A difficulty with the DIFFMASK score is the difficult statistics - a reply

    Research output: Contribution to journalLetterResearchpeer-review

  2. Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Time to onset of gastrointestinal bleeding in the SUP-ICU trial: a preplanned substudy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Cohort studies have indicated that avoidance of neuromuscular blocking agents (NMBA) is a risk factor for difficult tracheal intubation. However, the impact of avoiding NMBA on tracheal intubation, possible adverse effects, and postoperative discomfort has not been evaluated in a systematic review of randomised trials. We searched several databases for trials published until January 2017. We included randomised controlled trials comparing the effect of avoiding vs using NMBA. Two independent authors assessed risk of bias and extracted data. The risk of random errors was assessed by trial sequential analysis (TSA). We included 34 trials (3565 participants). In the four trials judged to have low risk of bias, there was an increased risk of difficult tracheal intubation with no use of NMBA [random-effects model, risk ratio (RR) 13.27, 95% confidence interval (CI) 8.19-21.49, P<0.00001, TSA-adjusted CI 1.85-95.04]. The result was confirmed when including all trials, (RR 5.00, 95% CI 3.49-7.15, P<0.00001, TSA-adjusted CI 1.20-20.77). There was a significant risk of upper airway discomfort or injury by avoiding NMBA (RR=1.37, 95% CI 1.09-1.74, P=0.008, TSA-adjusted CI 1.00-1.86). None of the trials reported mortality. Avoiding NMBA was significantly associated with difficult laryngoscopy, (RR 2.54, 95% CI 1.53-4.21, P=0.0003, TSA-adjusted CI 0.27-21.75). In a clinical context, one must balance arguments for using NMBA when performing tracheal intubation.

Original languageEnglish
JournalBritish Journal of Anaesthesia
Issue number6
Pages (from-to)1381-1393
Number of pages13
Publication statusPublished - Jun 2018

ID: 54150392